The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001057370p
Ethics application status
Help: Ethics application status
Not yet submitted
Date submitted
Help: Date submitted
4/07/2026
Date registered
Help: Date registered
26/08/2026
Date last updated
Help: Date last updated
26/08/2026
Date data sharing statement initially provided
Help: Data sharing statement date
26/08/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Can Skin Be Gently Stretched to Close Wounds? A Pilot Study of a New Closure Technique for Adults with Skin Defects Caused by Surgery or Injury.
Scientific title
Boot-Lace Assisted Immediate Tissue Expansion versus Conventional Reconstruction for Skin Defects of the Limbs and Trunk in Adults: A Pilot Randomised Controlled Trial Evaluating Scar Quality and Wound Outcomes
Additional trial identifiers [1] 317669 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Post-excisional skin defects 342472 0
Trauma-related skin defects 342839 0
Condition category
Condition code
Surgery 338597 338597 0 0
Surgical techniques
Cancer 338953 338953 0 0
Non melanoma skin cancer
Skin 339404 339404 0 0
Other skin conditions

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The intervention:

This trial involves two surgical interventions compared in a parallel-arm randomised design:
Control Arm (Group 1) — Conventional Reconstruction:
Standard surgical closure of post-excision or post-trauma skin defects using one of three techniques selected by the treating surgeon based on clinical suitability: local or regional flap (Group 1a), full-thickness skin graft (FTSG) (Group 1b), or split-thickness skin graft (SSG) (Group 1c).

Intervention Arm (Group 2) — Boot-Lace Assisted Immediate Tissue Expansion:
A surgical wound closure technique in which suture material is applied in a boot-lace (shoelace) crossing configuration across the wound defect to distribute tension multi-directionally, harnessing the viscoelastic properties of skin (mechanical creep and stress relaxation) to achieve direct wound closure without donor site harvest. Participants in Group 2 will be further allocated to:
Group 2a: Boot-lace technique alone
Group 2b: Boot-lace technique combined with the Khouri Percutaneous Mesh Expansion (PME) technique, in which multiple small needle perforations are made in the surrounding dermo-epidermis to enhance local tissue elasticity and expand the available tissue reservoir for closure

Delivery:
Both interventions will be delivered by doctors from the plastics and reconstructive surgery team at Gold Coast Health, who have training and extensive experience in this field. The first 10 surgeries in Group 2 will be performed or directly assisted by consultant surgeons, while the following 10 surgeries will be performed by PHOs or registrars under consultant supervision.

Frequency and length:
Each person undergoes a single surgical procedure, unless additional procedures are medically deemed necessary. Boot lace technique may add minimal additional operative time compared with conventional reconstruction. operative time will be formally recorded as a secondary outcome measure for comparison between arms. Post-operative wound management will continue until the wound no longer requires dressings, with the time to this endpoint recorded as a primary healing outcome.

Location:
Surgical procedures may be performed at Gold Coast University Hospital, Robina Hospital, or Varsity Day Surgery Hospital. Follow up may be at Gold Coast University Hospital or Robina Hospital clinics.

Adherence:
Participants will be scheduled for follow-up appointments at defined time points. Appointment reminders will be sent out via phone call or text-message. Where participants are unable to attend in person, telephone follow-up will be arranged where clinically appropriate.
Any intraoperative reversion to conventional technique, requirement for additional procedures, or other protocol deviations will be documented in the case report form and reported to the principal investigators for review.
Intervention code [1] 334503 0
Treatment: Surgery
Description of the comparator or control
Comparator:
Standard surgical reconstruction of post-excision or post-trauma skin defects using conventional techniques: local or regional flap (Group 1a), full-thickness skin graft (Group 1b), or split-thickness skin graft (Group 1c), selected by the treating surgeon based on individual clinical suitability. These represent current best-practice standard of care at this institution.

Delivery:
Delivered by the same doctors within the plastic and reconstructive department responsible for the intervention arm, with equivalent specialist training and expertise. This ensures any observed differences in outcome between arms reflect the technique rather than operator skill.

Delivery:
Individual, face-to-face, single operative procedure performed in an elective surgical theatre under local anaesthetic, sedation, or general anaesthetic as clinically appropriate.

Frequency and length:
A single surgical procedure. Post-operative wound management continues until the wound no longer requires dressings, with healing time recorded as an outcome measure.

Location:
Surgical procedures may be performed at Gold Coast University Hospital, Robina Hospital, or Varsity Day Surgery Hospital. Follow-up may be at Gold Coast University Hospital or Robina Hospital clinics.

Adherence:
Participants will be scheduled for follow-up appointments at defined time points. Appointment reminders will be sent out via phone call or text message. Where participants are unable to attend in person, a telephone follow-up will be arranged where clinically appropriate.
Any protocol deviation documentation will be identical to the intervention arm, ensuring comparability of follow-up intensity between groups.
Control group
Active

Outcomes
Primary outcome [1] 345883 0
Scar quality
Timepoint [1] 345883 0
Weekly for the first 4 weeks then at 3 month mark then 6 month mark post-operatively
Primary outcome [2] 345884 0
Wound healing time
Timepoint [2] 345884 0
Number of days to wound closure where the wound does not require dressings.
Secondary outcome [1] 463610 0
Pain score
Timepoint [1] 463610 0
At weeks 1 and 2 and at every subsequent follow-up post-operatively
Secondary outcome [2] 463613 0
Analgesic requirement
Timepoint [2] 463613 0
at first week and the second week and every subsequent follow up post-operatively
Secondary outcome [3] 463615 0
Complication rate including: wound dehiscence, necrosis, infection, haematoma, and requirement for additional procedures
Timepoint [3] 463615 0
As documented by the doctor at each clinical encounter (week 1 and 2 and month 3 and 6 post-operatively or as clinically indicated) and until the conclusion of the study.
Secondary outcome [4] 463616 0
Patient satisfaction
Timepoint [4] 463616 0
At 3 and 6 months post-operatively
Secondary outcome [5] 463617 0
Operation time
Timepoint [5] 463617 0
The time from the start to the completion of the surgery
Secondary outcome [6] 463620 0
The need for hospitalisation and duration
Timepoint [6] 463620 0
The need for hospitalisation and the duration of hospital stay
Secondary outcome [7] 463621 0
Donor site morbidity (Control arm/Group 1 only)
Timepoint [7] 463621 0
From the beginning to the completion of the study
Secondary outcome [8] 463622 0
Tissue assessment including: tissue pliability, contracture, trophic changes, and sensory changes (this will be assessed as a composite outcome).
Timepoint [8] 463622 0
at 3 and 6 months post-operatively
Secondary outcome [9] 463623 0
Requirement for re-excision and timing thereof
Timepoint [9] 463623 0
From the beginning to the end of the study
Secondary outcome [10] 464425 0
Cost effectiveness
Timepoint [10] 464425 0
At 2 weeks post-operatively

Eligibility
Key inclusion criteria
• Adult patients (18 years or older) presenting for elective excision of basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) or post-traumatic event.
• Post-excision or post-trauma defect located on the upper or lower limbs (including dorsum of hands and feet) or trunk (anterior or posterior).
• Defect deemed not directly closable by conventional technique by the treating consultant.
• Capacity to provide informed consent.
• Ability to attend follow-up appointments.
Minimum age
18 Years
Maximum age
80 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
• Defect location: face, ears, knees, ankles, plantar foot, volar hands, or flexion aspects of major joints (elbows, popliteal fossa, axillae — subject to investigator review). These sites carry elevated risk of functional compromise, contracture, or poor cosmesis with tension-based closure techniques.
• Fitzpatrick skin type 5 or 6 (pilot phase — due to elevated keloid and hypertrophic scarring risk).
• Melanoma, inadequately excised or recurrent BCC/SCC, or soft tissue malignant tumours requiring post-excision reconstruction. Complex oncological management requirements and potential need for further excision or adjuvant therapy may confound wound closure outcomes.
• Long-term systemic corticosteroids exceeding 10mg Prednisolone daily or equivalent. Chronic steroid use impairs wound healing and increases risk of skin fragility, dehiscence, and infection.
• Fragile skin conditions (e.g. dermatoporosis, cutaneous T-cell lymphoma). Compromised skin integrity increases the risk of tissue tearing and wound failure under the tension required by the boot-lace technique.
• Age greater than 80 years. Advanced age is associated with impaired wound healing, skin fragility, and increased operative risk.
• Active chemotherapy. Cytotoxic agents impair wound healing and increase infection risk, confounding outcome assessment.
• Previous radiation to the operative site. Radiation-damaged tissue has impaired vascularity and healing capacity, increasing complication risk with tension-based closure.
• Personal history of keloid or hypertrophic scarring. Pre-existing tendency to pathological scarring would confound scar outcome assessment and may be worsened by wound tension.
• Prior skin grafts within 10cm of the planned defect. Previous grafting alters local tissue architecture and elasticity, compromising the tissue expansion required for boot-lace closure.
• Requirement for further excision or skin grafts/flaps at time of index procedure. Co-existing reconstructive requirements would confound outcome attribution to the trial technique.
• Intraoperative complications (infection, haematoma, bleeding) altering healing trajectory — exclusion from trial but not from clinical care. Complications such as uncontrolled bleeding or infection would independently affect wound healing outcomes, confounding trial results.


Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Group assignment will be concealed using sequentially numbered, sealed opaque envelopes prepared by a team member not involved in participant recruitment or surgical care, opened only after the participant has provided informed consent and eligibility is confirmed.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
The randomisation sequence will be computer-generated using a validated online randomisation tool (e.g. Sealed Envelope or Research Randomizer) prior to trial commencement, with simple 1:1 randomisation between the two arms.
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 322205 0
Self funded/Unfunded
Name [1] 322205 0
Country [1] 322205 0
Primary sponsor type
Individual
Name
Anna Jolly Neriamparambil works at Gold Coast health
Address
Country
Australia
Secondary sponsor category [1] 325116 0
Individual
Name [1] 325116 0
Dilip Gahankari works at Gold Coast health
Address [1] 325116 0
Country [1] 325116 0
Australia

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 320731 0
Gold Coast Hospital and Health Service Human Research Ethics Committee
Ethics committee address [1] 320731 0
Ethics committee country [1] 320731 0
Australia
Date submitted for ethics approval [1] 320731 0
31/08/2026
Approval date [1] 320731 0
Ethics approval number [1] 320731 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151438 0
Mrs Anna Jolly Neriamparambil
Address 151438 0
1 Hospital Blvd, Southport QLD 4215, Gold Coast University Hospital
Country 151438 0
Australia
Phone 151438 0
+61 406232985
Fax 151438 0
Email 151438 0
Contact person for public queries
Name 151439 0
Anna Jolly Neriamparambil
Address 151439 0
1 Hospital Blvd, Southport QLD 4215, Gold Coast University Hospital
Country 151439 0
Australia
Phone 151439 0
+61 406232985
Fax 151439 0
Email 151439 0
Contact person for scientific queries
Name 151440 0
Anna Jolly Neriamparambil
Address 151440 0
1 Hospital Blvd, Southport QLD 4215, Gold Coast University Hospital
Country 151440 0
Australia
Phone 151440 0
+61 406232985
Fax 151440 0
Email 151440 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

TypeCitationLinkEmailOther DetailsAttachment
Study protocol    BootLace.docx


Results publications and other study-related documents

Documents added manually
TypeIs Peer Reviewed?DOICitations or Other DetailsAttachment
Statistical analysis planNo Statistical Analysis Plan.docx

Documents added automatically
No additional documents have been identified.